A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide clear benefits for heart attack patients ...

A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...

Two new studies point in opposite directions. A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide ...

Long-term use of beta-blockers in patients with myocardial infarction and preserved heart function does not significantly change quality of life or well-being compared to no beta-blockers. This is ...

Beta blockers are go-to meds for many people who've survived a heart attack. However, new Swedish research has found that they might not be needed for heart attack survivors whose hearts have retained ...

Recent studies challenge the long-held belief that beta-blockers are universally beneficial after a heart attack. Research indicates that these medications may not offer advantages for patients with ...

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine.

A type of drug used to help treat heart attacks does not work on the majority of patients and may actually contribute to hospitalization and death for women, new research has found. However, a study ...